Dr. Sadasivan Vidyasagar, assistant professor in the department of radiation oncology, serves as the principal inventor with a UF research team that developed enterade®, a combination of proprietary amino acid blends to help patients with GI issues related to cancer or chronic GI disease.

They may be key to saving wild sea turtles from tumors associated with turtle-specific herpes.

Mavis Agbandje-McKenna, Ph.D., a professor in the University of Florida’s College of Medicine’s Department of Biochemistry and Molecular Biology, discusses her research on the structural biology of viruses.

Small interfering RNA sounds like something from a science fiction novel rather than a revolutionary type of medicine.

David C. Bloom, Ph.D., a professor in the University of Florida’s College of Medicine’s Department of Molecular Genetics and Microbiology is a virologist who is developing novel therapies to treat Herpes Simplex Virus (HSV) by modifying proteins that regulate latency and activation in the HSV genome.

Thomas F. Stringer, M.D., a board-certified urologist and associate chairman of UF Health Urology, provides an expert’s perspective on a disease that affects 11 percent of men: prostate cancer. September is Prostate Cancer Awareness Month.

Nicholas Muzyczka, Ph.D., an Eminent Scholar in the University of Florida College of Medicine’s Department of Molecular Genetics and Microbiology, discusses his research on adeno-associated virus and gene therapy.

New colorectal cancer screening guidelines no longer make colonoscopies a rite of passage for 50-year-olds. Instead, 45-year-olds will celebrate their mid-forties by making an appointment most people dread.